OVID סך נכסי הפעילות העסקית Ovid Rx

Ovid Therapeutics Inc. (OVID) environmental policy is limited to digital document management and laboratory safety. Business sustainability relies on successful drug trials for rare brain pathologies and the availability of development capital. The company's price chart reflects total assets at 154.66, while the delivery of complex molecules requires strict adherence to temperature controls throughout all transportation stages.

For Ovid Therapeutics Inc. (OVID), which is developing epilepsy drugs, the trend in total assets reflects the biotech company's ability to accumulate resources for expansion within the neurotherapy market. This metric represents the sum of capital and liabilities, calculated inversely via ROA, allowing investors to assess the actual scale of the material base and the long-term financial stability of the business.